Back to Carlyle Group Inc. Carlyle Group Inc.

QTTBQTTB
10 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in Q32 BIO INC

Yes. Carlyle Group holds 60,363 shares of QTTB (Q32 Bio), worth $769,020, as of its Q2 2026 13F filing. It reduced the position by 1,042,378 shares (-94.5%) from Q1 2026. Carlyle Group has held QTTB since Q1 2024, across 10 quarterly 13F filings.

Current Value

$769,020

Current Shares

60,363

Total Value Change

-$17.3M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
60,363
-94.5%
$769,0200.0%$12.74
0
2026-Q1
Unchanged
1.1M
0.0%
$7.1M0.1%$4.89
0
2025-Q4
Unchanged
1.1M
0.0%
$3.6M0.0%$3.20
0
2025-Q3
Unchanged
1.1M
0.0%
$2.1M0.0%$1.94
0
2025-Q2
Unchanged
1.1M
0.0%
$1.6M0.0%$1.45
0
2025-Q1
Unchanged
1.1M
0.0%
$1.8M0.0%$1.71
0
2024-Q4
Unchanged
1.1M
0.0%
$3.8M0.1%$3.11
0
2024-Q3
Unchanged
1.1M
0.0%
$48.6M5.1%$46.00
0
2024-Q2
Unchanged
1.1M
0.0%
$19.2M1.8%$17.95
0
2024-Q1
New
1.1M
-
$18.1M1.1%$17.04
66

Other major holders of QTTB: RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used